J.P. Morgan Maintains Neutral Rating On HSIC

Yesterday morning, Henry Schein, Inc. HSIC reported 4Q10 EPS of $1.00, “above our $0.94 estimate and Bloomberg consensus of $0.96,” J.P. Morgan reports. “In addition, the company reaffirmed the prior 2011 EPS guidance,” J.P. Morgan writes. “We continue to remain cautious on HSIC given the potential ongoing impact of the economy across each of the company's business segments. “While we saw some nice improvement across parts of the business, it is unclear if this is sustainable. Finally, we believe the prospects of an improving economy are already being reflected in the current valuation.” J.P. Morgan maintains its Neutral rating on shares of Henry Schein, which closed Tuesday at $66.92.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsHealth CareHealth Care Distributorshenry scheinJ.P. Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!